[HTML][HTML] Cost-Effectiveness of apixaban compared with edoxaban for stroke prevention in nonvalvular atrial fibrillation
GYH Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical Therapeutics, 2015 - Elsevier
Purpose The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
[HTML][HTML] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn… - Clinical …, 2015 - clinicaltherapeutics.com
Purpose The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
[PDF][PDF] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical …, 2015 - scholar.archive.org
Purpose: The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
[PDF][PDF] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical …, 2015 - cyberleninka.org
Purpose: The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
[PDF][PDF] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical …, 2015 - core.ac.uk
Purpose: The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical …, 2015 - infona.pl
The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg BID
versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation.
GY Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical …, 2015 - europepmc.org
Purpose The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn, H Phatak… - Clinical …, 2015 - vbn.aau.dk
PURPOSE: The purpose of this analysis was to assess the cost-effectiveness of apixaban 5
mg BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended …
mg BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended …
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
GYH Lip, T Lanitis, T Kongnakorn… - Clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Purpose The purpose of this analysis was to assess the cost-effectiveness of apixaban 5 mg
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …
BID versus high-and low-dose edoxaban (60 mg and 30 mg once daily) as intended starting …